发明名称 USE OF AMINOSALICYLATES IN DIARRHOEA-PREDOMINENT IRRITABLE BOWEL SYNDROME
摘要 A method for the treatment or prophylaxis of non-inflammatory bowel diseases, diarrhoea-predominant irritable bowel syndrome or other non-specific bowel disorder is disclosed comprising administering to a patient in need of such treatment or prophylaxis an effective amount of balsalazide, or a 4-ASA or 5-ASA compound modified to include a 4-ABA side chain, or a salt or a derivative thereof, or a composition comprising balsalazide the modified compound, or a salt or a derivative thereof together with a suitable carrier. Use of balsalazide, a 4-ASA or 5-ASA compound modified to include a 4-ABA side chain, or a salt or derivative thereof, for the manufacture of a medicament for the treatment or prophylaxis of non-inflammatory bowel diseases, diarrhoea-pre-dominant irritable Bowel Syndrome or other non-specific bowel disorder is also disclosed.
申请公布号 US2015164923(A1) 申请公布日期 2015.06.18
申请号 US201414585911 申请日期 2014.12.30
申请人 Salix Pharmaceuticals, Ltd 发明人 Shortis Nicolas Peter
分类号 A61K31/655;A61K31/437 主分类号 A61K31/655
代理机构 代理人
主权项 1. A method for the treatment or prophylaxis of non-inflammatory bowel diseases, diarrhoea-predominant irritable bowel syndrome or other non-specific bowel disorder comprising administering to a patient in need of such treatment or prophylaxis an effective amount of balsalazide or a salt thereof and rifaximin or a composition comprising balsalazide or a salt thereof and rifaximin together with a suitable carrier.
地址 Raleigh NC US